Todo Kenichi, Sakai Nobuyuki, Kono Tomoyuki, Hoshi Taku, Imamura Hirotoshi, Adachi Hidemitsu, Kohara Nobuo
Department of Neurology, Kobe City Medical Center General Hospital, Kobe, Japan.
Department of Neurosurgery, Kobe City Medical Center General Hospital, Kobe, Japan.
J Stroke Cerebrovasc Dis. 2016 May;25(5):1187-1191. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.027. Epub 2016 Feb 27.
Outcomes after successful endovascular therapy in acute ischemic stroke are associated with onset-to-reperfusion time (ORT) and the National Institutes of Health Stroke Scale (NIHSS) score. In intravenous recombinant tissue plasminogen activator therapy, the NIHSS-time score, calculated by multiplying onset-to-treatment time with the NIHSS score, has been shown to predict clinical outcomes. In this study, we assessed whether a similar combination of the ORT and the NIHSS score can be applied to predict the outcomes after endovascular therapy.
We retrospectively reviewed the charts of 128 consecutive ischemic stroke patients with successful reperfusion after endovascular therapy. We analyzed the association of the ORT, the NIHSS score, and the NIHSS-time score with good outcome (modified Rankin Scale score ≤ 2 at 3 months).
Good outcome rates for patients with NIHSS-time scores of 84.7 or lower, scores higher than 84.7 up to 127.5 or lower, and scores higher than 127.5 were 72.1%, 44.2%, and 14.3%, respectively (P < .01). Multivariate logistic regression analysis revealed that the NIHSS-time score was an independent predictor of good outcomes (odds ratio, .372; 95% confidence interval, .175-.789) after adjusting for age, sex, internal carotid artery occlusion, plasma glucose level, ORT, and NIHSS score.
The NIHSS-time score can predict good clinical outcomes after endovascular treatment.
急性缺血性卒中血管内治疗成功后的预后与发病至再灌注时间(ORT)及美国国立卫生研究院卒中量表(NIHSS)评分相关。在静脉注射重组组织型纤溶酶原激活剂治疗中,通过将发病至治疗时间与NIHSS评分相乘计算得出的NIHSS-时间评分已被证明可预测临床预后。在本研究中,我们评估了ORT与NIHSS评分的类似组合是否可用于预测血管内治疗后的预后。
我们回顾性分析了128例血管内治疗后成功再灌注的缺血性卒中患者的病历。我们分析了ORT、NIHSS评分及NIHSS-时间评分与良好预后(3个月时改良Rankin量表评分≤2)之间的关联。
NIHSS-时间评分≤84.7、>84.7至≤127.5及>127.5的患者良好预后率分别为72.1%、44.2%和14.3%(P<0.01)。多因素logistic回归分析显示,在调整年龄、性别、颈内动脉闭塞、血糖水平、ORT及NIHSS评分后,NIHSS-时间评分是良好预后的独立预测因素(比值比,0.372;95%置信区间,0.175-0.789)。
NIHSS-时间评分可预测血管内治疗后的良好临床预后。